ACG Wealth’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $340K | Buy |
4,215
+96
| +2% | +$8.63K | 0.08% | 190 |
|
|
2022
Q2 | $370K | Sell |
4,119
-724
| -15% | -$73.4K | 0.08% | 192 |
|
|
2022
Q1 | $537K | Buy |
4,843
+125
| +3% | +$13.2K | 0.1% | 168 |
|
|
2021
Q4 | $488K | Buy |
4,718
+1,978
| +72% | +$229K | 0.07% | 213 |
|
|
2021
Q3 | $343K | Buy |
2,740
+5
| +0.2% | +$647 | 0.05% | 231 |
|
|
2021
Q2 | $339K | Sell |
2,735
-51
| -2% | -$6.4K | 0.04% | 234 |
|
|
2021
Q1 | $329K | Buy |
2,786
+59
| +2% | +$6.92K | 0.04% | 236 |
|
|
2020
Q4 | $319K | Sell |
2,727
-424
| -13% | -$46.7K | 0.04% | 230 |
|
|
2020
Q3 | $327K | Buy |
3,151
+6
| +0.2% | +$603 | 0.05% | 214 |
|
|
2020
Q2 | $288K | Sell |
3,145
-145
| -4% | -$13.9K | 0.05% | 216 |
|
|
2020
Q1 | $297K | Sell |
3,290
-97
| -3% | -$10.3K | 0.06% | 227 |
|
|
2019
Q4 | $384K | Buy |
3,387
+369
| +12% | +$40.5K | 0.06% | 240 |
|
|
2019
Q3 | $328K | Buy |
3,018
+60
| +2% | +$6.26K | 0.05% | 253 |
|
|
2019
Q2 | $288K | Sell |
2,958
-16
| -0.5% | -$1.46K | 0.04% | 278 |
|
|
2019
Q1 | $271K | Sell |
2,974
-89
| -3% | -$7.97K | 0.04% | 276 |
|
|
2018
Q4 | $279K | Buy |
3,063
+170
| +6% | +$15.9K | 0.04% | 251 |
|
|
2018
Q3 | $285K | Buy |
2,893
+5
| +0.2% | +$462 | 0.04% | 258 |
|
|
2018
Q2 | $247K | Buy |
2,888
+164
| +6% | +$13.7K | 0.04% | 249 |
|
|
2018
Q1 | $218K | Sell |
2,724
-243
| -8% | -$20K | 0.03% | 275 |
|
|
2017
Q4 | $240K | Buy |
2,967
+60
| +2% | +$4.8K | 0.04% | 278 |
|
|
2017
Q3 | $226K | Sell |
2,907
-156
| -5% | -$13K | 0.04% | 239 |
|
|
2017
Q2 | $272K | Buy |
+3,063
| New | +$258K | 0.04% | 247 |
|
|
2017
Q1 | – | Sell |
-3,072
| Closed | -$219K | – | 307 |
|
|
2016
Q4 | $219K | Sell |
3,072
-109
| -3% | -$8.56K | 0.05% | 208 |
|
|
2016
Q3 | $275K | Buy |
3,181
+577
| +22% | +$50.3K | 0.06% | 196 |
|
|
2016
Q2 | $226K | Buy |
+2,604
| New | +$211K | 0.05% | 199 |
|
|
2016
Q1 | – | Sell |
-3,239
| Closed | -$249K | – | 236 |
|
|
2015
Q4 | $249K | Sell |
3,239
-127
| -4% | -$9.56K | 0.06% | 185 |
|
|
2015
Q3 | $225K | Sell |
3,366
-1,496
| -31% | -$110K | 0.06% | 181 |
|
|
2015
Q2 | $360K | Buy |
4,862
+930
| +24% | +$71.1K | 0.09% | 152 |
|
|
2015
Q1 | $307K | Buy |
+3,932
| New | +$298K | 0.08% | 165 |
|
|
2014
Q4 | – | Sell |
-4,855
| Closed | -$301K | – | 210 |
|
|
2014
Q3 | $301K | Buy |
+4,855
| New | +$309K | 0.09% | 157 |
|
Other funds holding MDT
ACG Wealth's MDT Position: Q3 2022 in Review
ACG Wealth increased its Medtronic (MDT) stake by 2.3% in Q3 2022, buying an estimated $8.63K and bringing the position to 4,215 shares worth $340K. The position accounts for 0.08% of the portfolio, ranked #190.
ACG Wealth first reported a position in MDT in Q3 2014 and has held it in 30 quarters since. The position peaked at $537K in Q1 2022. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- ACG Wealth held 4,215 shares of Medtronic worth $340K as of Q3 2022.
- ACG Wealth bought 96 Medtronic shares in Q3 2022, an estimated $8.63K.
- Medtronic made up 0.08% of ACG Wealth's portfolio in Q3 2022, its #190 holding.
- ACG Wealth first reported a position in Medtronic in Q3 2014 and has held it in 30 quarters since.
- ACG Wealth's Medtronic position peaked at $537K in Q1 2022.
- 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.